The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics
Open accessAbstract
Irritable bowel syndrome (IBS) is a multi-factorial gastrointestinal condition affecting 8–22 % of the population with a higher prevalence in women and accounting for 20–50 % of referrals to gastroenterology clinics. It is characterised by abdominal pain, excessive flatus, variable bowel habit and abdominal bloating for which there is no evidence of detectable organic disease. Suggested aetiologies include gut motility and psychological disorders, psychophysiological phenomena and colonic malfermentation. The faecal microflora in IBS has been shown to be abnormal with higher numbers of facultative organisms and low numbers of lactobacilli and bifidobacteria. Although there is no evidence of food allergy in IBS, food intolerance has been identified and exclusion diets are beneficial to many IBS patients. Food intolerance may be due to abnormal fermentation of food residues in the colon, as a result of disruption of the normal flora. The role of probiotics in IBS has not been clearly defined. Some studies have shown improvements in pain and flatulence in response to probiotic administration, whilst others have shown no symptomatic improvement. It is possible that the future role of probiotics in IBS will lie in prevention, rather than cure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
The control and consequences of bacterial fermentation in the human colon
Cummings, J. H., & Macfarlane, G. T. (1991) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1991.tb02739.x · Cited by 1,499
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
Neal, K. R., Hebden, J., & Spiller, R. (1997) · BMJ · doi:10.1136/bmj.314.7083.779 · Cited by 586
Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome
Serra, J. (2001) · Gut · doi:10.1136/gut.48.1.14 · Cited by 340
Food intolerance and the irritable bowel syndrome.
Nanda, R., James, R., Smith, H., Dudley, C. R., & Jewell, D. P. (1989) · Gut · doi:10.1136/gut.30.8.1099 · Cited by 307 · cited 2×
“Nanda et al. (1989) invited 200 patients with IBS to take part in an exclusion diet for three weeks.”
BackgroundWyatt, G. M., Bayliss, C. E., Lakey, A. F., Bradley, H. K., Hunter, J. O., & Jones, V. A. (1988) · Journal of Medical Microbiology · doi:10.1099/00222615-26-4-295 · Cited by 34
Self-citation
Cited by
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 997
Potential Uses of Probiotics in Clinical Practice
Reid, G., Jass, J., Sebulsky, M. T., & McCormick, J. K. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.658-672.2003 · Cited by 912
Gareau, M. G., Jury, J., MacQueen, G., Sherman, P. M., & Perdue, M. H. (2007) · Gut · doi:10.1136/gut.2006.117176 · Cited by 472
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
The role of the intestinal microbiota in the development of atopic disorders
Penders, J., Stobberingh, E. E., Brandt, P. A. V. D., & Thijs, C. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01462.x · Cited by 437
Probiotics: Considerations for Human Health
Sanders, M. E. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.marr.91-99 · Cited by 422
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
Sheehan, V. M., Ross, P., & Fitzgerald, G. F. (2007) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2007.01.007 · Cited by 317
Mättö, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A., & Saarela, M. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.08.009 · Cited by 301
“Some early studies have reported differences in faecal bacterial population between IBS and control subjects [12–14].”
BackgroundFermentation of pomegranate juice by probiotic lactic acid bacteria
Mousavi, Z. E., Mousavi, S. M., Razavi, S. H., Emam-Djomeh, Z., & Kiani, H. (2011) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-010-0436-1 · Cited by 293
Guglielmetti, S., Mora, D., Gschwender, M., & Popp, K. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04633.x · Cited by 287
“Possible answers were: “completely relieved (1), considerably relieved (2), somewhat 175”
BackgroundShori, A. B. (2016) · Food Bioscience · doi:10.1016/j.fbio.2015.11.001 · Cited by 271
A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
Codling, C., O’Mahony, L., Shanahan, F., Quigley, E. M. M., & Marchesi, J. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0934-x · Cited by 243
Microbiota and the gut–brain axis
Bienenstock, J., Kunze, W., & Forsythe, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv019 · Cited by 234
“Altered gut microbiota can also be responsible for pathophysiology in the colon.(19,20) Gut microbiota–host misadaptation (dysbiosis) has been implicated in the rising incidence of inflammatory diseases such as inflammatory bowel disease.”
BackgroundKnowles, S. R., Nelson, E. A., & Palombo, E. A. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2007.09.010 · Cited by 192
NIV, E., NAFTALI, T., HALLAK, R., & VAISMAN, N. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.06.001 · Cited by 191
Verdú, E. F., Bercík, P., Bergonzelli, G. E., Huang, X.-X., Blennerhasset, P., Rochat, F., Fiaux, M., Mansourian, R., Corthésy-Theulaz, I., & Collins, S. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.007 · Cited by 180
Eutamene, H., Lamine, F., Chabo, C., Theodorou, V., Rochat, F., Bergonzelli, G. E., Corthésy-Theulaz, I., Fioramonti, J., & Bueno, L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.8.1901 · Cited by 169
Maukonen, J., Satokari, R., Mättö, J., Söderlund, H., Mattila-Sandholm, T., & Saarela, M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46134-0 · Cited by 156
WILLIAMS, E. A., STIMPSON, J., WANG, D., PLUMMER, S., GARAIOVA, I., BARKER, M. E., & CORFE, B. M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03848.x · Cited by 156
Quigley, E. M. M., & Flourie, B. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00879.x · Cited by 151
Azpiroz, F., & Malagelada, J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.062 · Cited by 127
Stigma and irritable bowel syndrome: a taboo subject?
Hearn, M., Whorwell, P. J., & Vasant, D. H. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30348-6 · Cited by 88
Madden, J. A. J., Plummer, S. F., Tang, J., Garaiova, I., Plummer, N. T., Herbison, M., Hunter, J. O., Shimada, T., Cheng, L., & Shirakawa, T. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.02.006 · Cited by 86
Sullivan, Å., Nord, C. E., & Evengård, B. (2009) · Nutrition Journal · doi:10.1186/1475-2891-8-4 · Cited by 80
Nutritional care of the patient with constipation
Fernández-Bañares, F. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.11.002 · Cited by 65
Wierdsma, N. J., van Bodegraven, A. A., Uitdehaag, B. M. J., Arjaans, W., Savelkoul, P. H. M., Kruizenga, H. M., & van Bokhorst-de van der Schueren, M. A. E. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902839675 · Cited by 33
S. Kim, L., Hilli, L., Orlowski, J., Kupperman, J. L., Baral, M., & F. Waters, R. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9297-8 · Cited by 30
The Use of Probiotics in Functional Bowel Disease
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20
“The overall impact of probiotics, in IBS, remains unclear [88–92].”
BackgroundProbiotics in irritable bowel syndrome: an immunomodulatory strategy?
Quigley, E. M. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719648 · Cited by 19
Metadata
- Authors
- Madden, J. A. J., & Hunter, J. O.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2002-09
- Volume
- 88
- Issue
- S1
- Pages
- s67-s72
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2105480697
- Cited by
- 173
- References
- 7
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.